De Cristofaro, Raimondo
De Cristofaro, Raimondo
ROMA - Dipartimento di Medicina e chirurgia traslazionale
Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini‐Delphi Consensus
2022 Coppola, A.; Franchini, M.; Pappagallo, G.; Borchiellini, A.; De Cristofaro, R.; Molinari, A. C.; Santoro, R. C.; Santoro, C.; Tagliaferri, A.
Measurement of extended half-life recombinant FVIII molecules: In vitro and ex vivo evidence of relevant assay discrepancies
2023 Lancellotti, Stefano; Sacco, Monica; Tardugno, Maira; Mancuso, Maria Elisa; De Cristofaro, Raimondo
Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience
2022 Cesari, Francesca; Sorrentino, Silvia; Maria Gori, Anna; Rogolino, Angela; De Cristofaro, Raimondo; Giusti, Betti; Sticchi, Elena; De Candia, Erica; Marcucci, Rossella
ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study
2022 Sacco, Monica; Tardugno, Maira; Lancellotti, Stefano; Ferretti, Antonietta; Ponziani, Francesca Romana; Riccardi, Laura; Zocco, Maria Assunta; De Magistris, Antonio; Santopaolo, Francesco; Pompili, Maurizio; De Cristofaro, Raimondo
Low ADAMTS-13/VWF ratio and altered gut-liver axis predict complications of advanced chronic liver disease: a pilot study
2022 Ponziani, Francesca Romana; Sacco, Monica; Tardugno, Maira; Santopaolo, Francesco; Marsico, Adriana; Manna, Stefano; Lancellotti, Stefano; Gasbarrini, Antonio; De Cristofaro, Raimondo; Pompili, Maurizio
Oral anticoagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the ORIGAMI pilot investigation
2022 D'Amario, Domenico; Galli, Mattia; Cappannoli, Luigi; Canonico, Francesco; Restivo, Attilio; Arcudi, Alessandra; Scacciavillani, Roberto; E Riccioni, Maria; Vergallo, Rocco; A Montone, Rocco; Conte, Amelia; Meleo, Emiliana; Lancellotti, Stefano; Sacco, Monica; Antonelli, Massimo; Andreotti, Felicita; De Cristofaro, Raimondo; Crea, Filippo
Aims: The ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation (ORIGAMI) study investigates the safety and efficacy of Edoxaban administered via PEG in patients with atrial fibrillation and a clinical indication for a long-term anticoagulation. Design: In this prospective, single-centre observational study, 12 PEG-treated patients with indication to anticoagulation will receive edoxaban via PEG and will be followed up to 6 months. Plasma antifactor Xa activity and edoxaban concentrations will be assessed. Thromboembolic (ischaemic stroke, systemic embolism, venous thromboembolism) and bleeding events (Bleeding Academic Research Consortium and Thrombolysis in Myocardial Infarction) will be recorded at 1 and 6 months. Preliminary results: A retrospective analysis of five atrial fibrillation cases undergoing PEG implantation at our Institution who received edoxaban via PEG showed plasma anti-FXa levels at a steady state of 146 ± 15 ng/ml, without major adverse event at a mean follow-up of 6 months. Conclusion: ORIGAMI prospectively investigates PEG-administration of edoxaban in PEG-treated patients requiring long-term anticoagulation. Our preliminary retrospective data support this route of DOAC administration.
2021 1, Domenico D'Amario; Galli, Mattia; Canonico, Francesco; Restivo, Attilio; Arcudi, Alessandra; Scacciavillani, Roberto; Cappannoli, Luigi; Riccioni, Maria Elena; Giuseppina Annetta, Maria; Di Stefano, Gaetano; Piccinni, Carlo; Vergallo, Rocco; Antonio Montone, Rocco; Maria Leone, Antonio; Niccoli, Giampaolo; Sabatelli, Mario; Antonelli, Massimo; Andreotti, Felicita; De Cristofaro, Raimondo; Crea, Filippo
Oral Squamous Cell Carcinoma-Associated Thrombosis: What Evidence?
2022 Di Gennaro, Leonardo; De Cristofaro, Raimondo; Ferretti, A.; Basso, Maria; Riccio, C.; Cordaro, Massimo; Lajolo, Carlo
Direct oral anticoagulants and therapeutic adherence: do not let your guard down
2021 Di Gennaro, L.; Monaco, M.; Riccio, C.; De Candia, E.; Alberelli, M. A.; di Martino, C.; Basso, M.; Ferretti, M. A.; Lancellotti, S.; De Cristofaro, R.
Diagnosis and management of cerebral venous sinus thrombosis in children: a single-center retrospective analysis
2021 Lazzareschi, I.; Curatola, A.; Gatto, A.; Maellaro, F.; Frassanito, P.; Basso, M.; De Cristofaro, R.; Valentini, P.
Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration?
2021 Cappannoli, Luigi; Galli, Mattia; De Cristofaro, Raimondo; Crea, Filippo; D'Amario, Domenico
Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration?
2021 Cappannoli, L.; Galli, M.; De Cristofaro, R.; Crea, F.; D'Amario, D.
Direct oral anticoagulants in cancer patients: which help from the specialist hemostasis and thrombosis laboratory?
2021 Di Gennaro, L.; Marazzi, F.; De Cristofaro, R.
Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?
2021 Covino, M.; De Matteis, G.; Della Polla, D.; Burzo, M. L.; Pascale, M. M.; Santoro, M.; De Cristofaro, R.; Gasbarrini, A.; De Candia, E.; Franceschi, F.
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study
2021 D'Amario, D.; Galli, M.; Canonico, F.; Restivo, A.; Arcudi, A.; Scacciavillani, R.; Cappannoli, L.; Riccioni, M. E.; Annetta, M. G.; Di Stefano, G.; Piccinni, C.; Vergallo, R.; Montone, R. A.; Leone, A. M.; Niccoli, G.; Sabatelli, M.; Antonelli, M.; Andreotti, F.; De Cristofaro, R.; Crea, F.
From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19
2021 Vinci, R.; Pedicino, D.; Andreotti, F.; Russo, G.; D'Aiello, A.; De Cristofaro, R.; Crea, F.; Liuzzo, G.
Sirtuin 5, vascular endothelium and fibrinolysis: a deadly embrace?
2021 Rocca, Bianca; De Cristofaro, Raimondo
Hemophilia A and von Willebrand deficiency: therapeutic implications
2020 Basso, Maria; Lazzareschi, Ilaria; Curatola, Antonietta; Di Gennaro, Leonardo; Buonsenso, Danilo; Gatto, Antonio; De Candia, Erica; De Cristofaro, Raimondo
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D9D3 and D4 domains
2020 Sacco, M.; Lancellotti, S.; Ferrarese, M.; Bernardi, F.; Pinotti, M.; Tardugno, M.; de Candia, E.; Di Gennaro, L.; Basso, M.; Giusti, B.; Papi, M.; Perini, G.; Castaman, G.; de Cristofaro, R.
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study
2020 1, Domenico D'Amario; Galli, Mattia; Canonico, Francesco; Restivo, Attilio; Arcudi, Alessandra; Scacciavillani, Roberto; Cappannoli, Luigi; Riccioni, Maria Elena; Annetta, Maria Giuseppina; Di Stefano, Gaetano; Piccinni, Carlo; Vergallo, Rocco; Montone, Rocco Antonio; Leone, Antonio Maria; Niccoli, Giampaolo; Sabatelli, Mario; Antonelli, Massimo; Andreotti, Felicita; De Cristofaro, Raimondo; Crea, Filippo
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2022 | Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini‐Delphi Consensus | Coppola, A.; Franchini, M.; Pappagallo, G.; Borchiellini, A.; De Cristofaro, R.; Molinari, A. C.; Santoro, R. C.; Santoro, C.; Tagliaferri, A. | |
| 1-gen-2023 | Measurement of extended half-life recombinant FVIII molecules: In vitro and ex vivo evidence of relevant assay discrepancies | Lancellotti, Stefano; Sacco, Monica; Tardugno, Maira; Mancuso, Maria Elisa; De Cristofaro, Raimondo | |
| 1-gen-2022 | Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience | Cesari, Francesca; Sorrentino, Silvia; Maria Gori, Anna; Rogolino, Angela; De Cristofaro, Raimondo; Giusti, Betti; Sticchi, Elena; De Candia, Erica; Marcucci, Rossella | |
| 1-gen-2022 | ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study | Sacco, Monica; Tardugno, Maira; Lancellotti, Stefano; Ferretti, Antonietta; Ponziani, Francesca Romana; Riccardi, Laura; Zocco, Maria Assunta; De Magistris, Antonio; Santopaolo, Francesco; Pompili, Maurizio; De Cristofaro, Raimondo | |
| 1-gen-2022 | Low ADAMTS-13/VWF ratio and altered gut-liver axis predict complications of advanced chronic liver disease: a pilot study | Ponziani, Francesca Romana; Sacco, Monica; Tardugno, Maira; Santopaolo, Francesco; Marsico, Adriana; Manna, Stefano; Lancellotti, Stefano; Gasbarrini, Antonio; De Cristofaro, Raimondo; Pompili, Maurizio | |
| 1-gen-2022 | Oral anticoagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the ORIGAMI pilot investigation | D'Amario, Domenico; Galli, Mattia; Cappannoli, Luigi; Canonico, Francesco; Restivo, Attilio; Arcudi, Alessandra; Scacciavillani, Roberto; E Riccioni, Maria; Vergallo, Rocco; A Montone, Rocco; Conte, Amelia; Meleo, Emiliana; Lancellotti, Stefano; Sacco, Monica; Antonelli, Massimo; Andreotti, Felicita; De Cristofaro, Raimondo; Crea, Filippo | |
| 1-gen-2021 | Aims: The ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation (ORIGAMI) study investigates the safety and efficacy of Edoxaban administered via PEG in patients with atrial fibrillation and a clinical indication for a long-term anticoagulation. Design: In this prospective, single-centre observational study, 12 PEG-treated patients with indication to anticoagulation will receive edoxaban via PEG and will be followed up to 6 months. Plasma antifactor Xa activity and edoxaban concentrations will be assessed. Thromboembolic (ischaemic stroke, systemic embolism, venous thromboembolism) and bleeding events (Bleeding Academic Research Consortium and Thrombolysis in Myocardial Infarction) will be recorded at 1 and 6 months. Preliminary results: A retrospective analysis of five atrial fibrillation cases undergoing PEG implantation at our Institution who received edoxaban via PEG showed plasma anti-FXa levels at a steady state of 146 ± 15 ng/ml, without major adverse event at a mean follow-up of 6 months. Conclusion: ORIGAMI prospectively investigates PEG-administration of edoxaban in PEG-treated patients requiring long-term anticoagulation. Our preliminary retrospective data support this route of DOAC administration. | 1, Domenico D'Amario; Galli, Mattia; Canonico, Francesco; Restivo, Attilio; Arcudi, Alessandra; Scacciavillani, Roberto; Cappannoli, Luigi; Riccioni, Maria Elena; Giuseppina Annetta, Maria; Di Stefano, Gaetano; Piccinni, Carlo; Vergallo, Rocco; Antonio Montone, Rocco; Maria Leone, Antonio; Niccoli, Giampaolo; Sabatelli, Mario; Antonelli, Massimo; Andreotti, Felicita; De Cristofaro, Raimondo; Crea, Filippo | |
| 1-gen-2022 | Oral Squamous Cell Carcinoma-Associated Thrombosis: What Evidence? | Di Gennaro, Leonardo; De Cristofaro, Raimondo; Ferretti, A.; Basso, Maria; Riccio, C.; Cordaro, Massimo; Lajolo, Carlo | |
| 1-gen-2021 | Direct oral anticoagulants and therapeutic adherence: do not let your guard down | Di Gennaro, L.; Monaco, M.; Riccio, C.; De Candia, E.; Alberelli, M. A.; di Martino, C.; Basso, M.; Ferretti, M. A.; Lancellotti, S.; De Cristofaro, R. | |
| 1-gen-2021 | Diagnosis and management of cerebral venous sinus thrombosis in children: a single-center retrospective analysis | Lazzareschi, I.; Curatola, A.; Gatto, A.; Maellaro, F.; Frassanito, P.; Basso, M.; De Cristofaro, R.; Valentini, P. | |
| 1-gen-2021 | Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration? | Cappannoli, Luigi; Galli, Mattia; De Cristofaro, Raimondo; Crea, Filippo; D'Amario, Domenico | |
| 1-gen-2021 | Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration? | Cappannoli, L.; Galli, M.; De Cristofaro, R.; Crea, F.; D'Amario, D. | |
| 1-gen-2021 | Direct oral anticoagulants in cancer patients: which help from the specialist hemostasis and thrombosis laboratory? | Di Gennaro, L.; Marazzi, F.; De Cristofaro, R. | |
| 1-gen-2021 | Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? | Covino, M.; De Matteis, G.; Della Polla, D.; Burzo, M. L.; Pascale, M. M.; Santoro, M.; De Cristofaro, R.; Gasbarrini, A.; De Candia, E.; Franceschi, F. | |
| 1-gen-2021 | ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study | D'Amario, D.; Galli, M.; Canonico, F.; Restivo, A.; Arcudi, A.; Scacciavillani, R.; Cappannoli, L.; Riccioni, M. E.; Annetta, M. G.; Di Stefano, G.; Piccinni, C.; Vergallo, R.; Montone, R. A.; Leone, A. M.; Niccoli, G.; Sabatelli, M.; Antonelli, M.; Andreotti, F.; De Cristofaro, R.; Crea, F. | |
| 1-gen-2021 | From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19 | Vinci, R.; Pedicino, D.; Andreotti, F.; Russo, G.; D'Aiello, A.; De Cristofaro, R.; Crea, F.; Liuzzo, G. | |
| 1-gen-2021 | Sirtuin 5, vascular endothelium and fibrinolysis: a deadly embrace? | Rocca, Bianca; De Cristofaro, Raimondo | |
| 1-gen-2020 | Hemophilia A and von Willebrand deficiency: therapeutic implications | Basso, Maria; Lazzareschi, Ilaria; Curatola, Antonietta; Di Gennaro, Leonardo; Buonsenso, Danilo; Gatto, Antonio; De Candia, Erica; De Cristofaro, Raimondo | |
| 1-gen-2020 | Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D9D3 and D4 domains | Sacco, M.; Lancellotti, S.; Ferrarese, M.; Bernardi, F.; Pinotti, M.; Tardugno, M.; de Candia, E.; Di Gennaro, L.; Basso, M.; Giusti, B.; Papi, M.; Perini, G.; Castaman, G.; de Cristofaro, R. | |
| 1-gen-2020 | ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study | 1, Domenico D'Amario; Galli, Mattia; Canonico, Francesco; Restivo, Attilio; Arcudi, Alessandra; Scacciavillani, Roberto; Cappannoli, Luigi; Riccioni, Maria Elena; Annetta, Maria Giuseppina; Di Stefano, Gaetano; Piccinni, Carlo; Vergallo, Rocco; Montone, Rocco Antonio; Leone, Antonio Maria; Niccoli, Giampaolo; Sabatelli, Mario; Antonelli, Massimo; Andreotti, Felicita; De Cristofaro, Raimondo; Crea, Filippo |